Cargando…

PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies

Detalles Bibliográficos
Autores principales:	Guillen Astete, CA, García Campayo, L, Conde Campayo, B, Sifuentes Giraldo, A, Gamir Gamir, ML
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045607/ http://dx.doi.org/10.1186/1546-0096-11-S2-P46

Ejemplares similares

PReS-FINAL-2032: Changes in immunogenic profile in patients with juvenile idiopathic arthritis exposed to anti tumoral necrosis factor therapy
por: Guillen Astete, CA, et al.
Publicado: (2013)

PReS-FINAL-2168: Comparison of safety and retention rate of TNF antagonist therapy in juvenile-onset and adult-onset ankylosing spondylitis: data from the spanish registry biobadaser 2.0
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

PReS-FINAL-2115: Differences in musculoskeletal clinical expression between Spanish and Mexican patients with juvenile spondyloarthritis: data from the Mexespa project
por: Sifuentes Giraldo, WA, et al.
Publicado: (2013)

First episode of chronic anterior uveitis in patients with juvenile idiopathic arthritis and relationship with administrated treatments
por: Boteanu, Alina Lucica, et al.
Publicado: (2014)

Macrophage activation syndrome during treatment with biological therapy in patients with systemic juvenile idiopathic arthritis
por: Boteanu, Alina Lucica, et al.
Publicado: (2014)

PReS-FINAL-2043: Cardiac involvement in juvenile idiopathic arthritis
por: Rossetto, E, et al.
Publicado: (2013)

PReS-FINAL-2097: Evaluation of gait in children with juvenile idiopathic arthritis
por: Baydogan, SN, et al.
Publicado: (2013)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

PReS-FINAL-2165: Pharmacogenetic determinants of response to methotrexate in juvenile idiopathic arthritis
por: Pastore, S, et al.
Publicado: (2013)

PReS-FINAL-2081: Accelerometer-assessed daily activity in juvenile idiopathic arthritis
por: Noergaard, M, et al.
Publicado: (2013)

PReS-FINAL-2109: Genetic variations in patients with juvenile idiopathic arthritis and uveitis
por: Reinards, TH, et al.
Publicado: (2013)

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013)

PReS-FINAL-2018: The P53 gene polymorphisms and juvenile idiopathic arthritis
por: Kozhevnikov, A, et al.
Publicado: (2013)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

PReS-FINAL-2007: Adolescent clinic for young patients with juvenile idiopathic arthritis
por: Sørensen, SK
Publicado: (2013)

PReS-FINAL-2060: The role of stress factors in the onset of juvenile idiopathic arthritis
por: Stepanenko, N, et al.
Publicado: (2013)

PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
por: Vatta, P, et al.
Publicado: (2013)

PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis
por: Falcini, F, et al.
Publicado: (2013)

PReS-FINAL-2263: Progressive pseudorheumatoid dysplasia in differential diagnosis of juvenile idiopathic arthritis
por: Vrtíková, E, et al.
Publicado: (2013)

PReS-FINAL-2077: Lung function evaluation in a juvenile idiopathic arthritis cohort
por: Machado Vaz, I, et al.
Publicado: (2013)

PReS-FINAL-2061: Abatacept in therapy of juvenile idiopathic arthritis in real clinical practice
por: Arsenyeva, SV, et al.
Publicado: (2013)

PReS-FINAL-2066: Use of chiropractic care in danish children with juvenile idiopathic arthritis
por: Kuhn, KS, et al.
Publicado: (2013)

PReS-FINAL-2089: Temporomandibular joint involvement and quality of life in juvenile idiopathic arthritis
por: Frid, P, et al.
Publicado: (2013)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

PReS-FINAL-2155: Genetic variability of methotrexate transporters in patients with juvenile idiopathic arthritis
por: Zajc Avramovič, M, et al.
Publicado: (2013)

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
por: Goldenstein-Schainberg, C, et al.
Publicado: (2013)

PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

PReS-FINAL-2036: Proteins of the lectin pathway of the complement system in juvenile idiopathic arthritis
por: Petri, C, et al.
Publicado: (2013)

PReS-FINAL-2084: Prevalence of cervical spine involvement in children with juvenile idiopathic arthritis
por: Semolič, N, et al.
Publicado: (2013)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

PReS-FINAL-2160: Intestinal microbiome in polyarticular juvenile idiopathic arthritis: a pilot study
por: Hissink Muller, PC, et al.
Publicado: (2013)

PReS-FINAL-2099: Assessing the standards of oral health in children and adolescents with juvenile idiopathic arthritis
por: Trehane, SJ, et al.
Publicado: (2013)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis
por: Vastert, S, et al.
Publicado: (2013)

PReS-FINAL-2104: Disease course and predictors of outcome in systemic onset juvenile idiopathic arthritis
por: Soponkanaporn, S, et al.
Publicado: (2013)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

PReS-FINAL-2042: Health-related quality of-life in Turkish children and adolescents with juvenile idiopathic arthritis
por: Tarakci, E, et al.
Publicado: (2013)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0jriac3qntpk5kfspdtpfls6ao